Sort
48,018 grants matching “immunotherapy”
Engineered B Cells as a Universal Platform for the Treatment of Enzymopathies
$386,667Branden S Moriarity · University Of Minnesota · R01 · FY2021 · AI
Control of Effector and Memory T Cell Development by Inflammatory Signals
$386,661Susan M Kaech · Yale University · R01 · FY2011 · AI
Clinical Fellowship Training Program
$386,650Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2013 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$386,587James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$386,587James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Sublingual Immunotherapy for Peanut Allergy
$386,575Arvil Wesley Burks · Duke University · R01 · FY2009 · AT
A knowledge map to find Alzheimer's disease drugs
$386,555Olivier Lichtarge · Baylor College Of Medicine · R01 · FY2020 · AG
Mechanisms of radioresistance and strategies for radiosensitization in ovarian clear cell carcinoma
$386,539Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
eDyNAmiC - UCSD
$386,521Vineet Bafna · University Of California, San Diego · OT2 · FY2025 · CA
Proj 2 - Exploiting Therapeutic Vulnerabilities
$386,498William A Weiss · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA
A HIGHLY SUPERIOR AND SELECTIVE CANCER IMMUNOTHERAPY-BASED APPROACH FOR TRIPLE-NEGATIVE BREAST CANCERS
$386,494Rector & Visitors Of The University Of Virginia · · FY2018 · Defense Health Agency
Chemokine Modulation During SIV Infection & AIDS
$386,474Todd A Reinhart · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · AI
Inhibiting mitochondrial complex I to improve cetuximab efficacy in oral cancer
$386,463Yong Teng · Emory University · R01 · FY2024 · DE
Project 5: Enhancement of the Anti-Tumor Activity and Targeted Applications of Third Party Donor-Derived EBV-specific T-cells
$386,442Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2022 · CA
Amelioration of recurrent herpes keratitis
$386,437Patrick M Stuart · Washington University · R01 · FY2007 · EY
Immune Response to Polyomavirus Infection
$386,433Parmjeet S Randhawa · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · AI
Finger Nucleases to Specifically Disrupt Coreceptor Expression
$386,432Robert W. Doms · University Of Pennsylvania · U19 · FY2009 · AI
Allergen T cell epitopes and phenotypes during peanut immunotherapy
$386,424Erik Wambre · Benaroya Research Inst At Virginia Mason · U19 · FY2019 · AI
Epigenetic Regulation of Plasma Cells Differentiation
$386,421Jeremy M. Boss · Emory University · R01 · FY2020 · AI
Neoantigen-specific Adoptive T Cell Therapy for Glioblastoma, IND-BB-13135, protocol submitted 04/25/2020
$386,381Gary W. Wood · Tvax Biomedical, Inc. · R01 · FY2022 · FD
Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies
$386,376Jose R Conejo-Garcia · Duke University · R01 · FY2025 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$386,374Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2021 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$386,374Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2020 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$386,374Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2022 · CA
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
$386,325David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA